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Abstract We investigated the effect of estrogens on heart
mitochondrial functions and whether estrogens can prevent
calcium-induced release of cytochrome c from mitochondria.
10 nM^10 WM 17L-estradiol or 4-hydroxytamoxifen did not
affect mitochondrial respiration rate and membrane potential in
state 3 and state 4. Higher concentrations of both agents
decreased state 3 respiration rate and membrane potential. 100
nM 17L-estradiol and 4-hydroxytamoxifen blocked high cal-
cium-induced cytochrome c release from mitochondria but not
mitochondrial swelling. Thus, at physiological concentrations
estrogens do not affect mitochondrial respiratory functions but
protect heart mitochondria from high calcium-induced release of
cytochrome c. & 2002 Published by Elsevier Science B.V. on
behalf of the Federation of European Biochemical Societies.
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1. Introduction
Mitochondrial damage is a crucial event in the pathogenesis
of ischemic cell injury and especially in promoting cell death
by apoptosis [1^3]. Recent evidence suggests that apoptosis in
ischemic/reperfused heart can be triggered by cytochrome c
release from mitochondria leading to activation of caspases
[4,5]. Elevation of intracellular calcium has been implicated as
a causative damaging factor during heart ischemia/reperfu-
sion, and calcium-triggered opening of mitochondrial perme-
ability transition pore (MPT) has been shown to cause loss of
cytochrome c from mitochondria [6]. Estrogens appear to pre-
serve heart function in experimental models of ischemia-reper-
fusion [7,8] and to inhibit apoptosis in cardiomyocytes [9],
however the underlying cardioprotective mechanisms remain
poorly understood. There is evidence that the protective ef-
fects of estrogens are not restricted to binding to estrogen
receptors and subsequent changes in gene expression. Tran-
scription-independent actions of estrogens in myocardial is-
chemia and reperfusion have been suggested to be due to
stimulation of NO production, inhibition of myocardial cal-
cium accumulation or due to the antioxidant properties of
estrogens [8,10]. It has also been shown that 17L-estradiol
preserves mitochondrial structure and function during ische-
mia/reperfusion [8], however the mechanism is unclear.
Recently it has been shown that tamoxifen, a synthetic anti-
estrogenic agent widely used in treatment of breast cancer
[11], at low concentration inhibits MPT [12,13], which may
be implicated in ischemia-reperfusion injury and apoptosis
[14,15]. 4-Hydroxytamoxifen is a metabolite of tamoxifen
with higher a⁄nity for estrogen receptor but lacking the abil-
ity to induce apoptosis. Both tamoxifen and 4-hydroxytamox-
ifen are lipophilic molecules with high partitioning into mem-
branes [16], thus it is possible that their pharmacological
e¡ects are mediated by interactions with mitochondrial mem-
branes.
In the present study, we aimed to elucidate the e¡ect of
17L-estradiol and 4-hydroxytamoxifen on heart mitochondrial
functions and whether at physiological concentrations they
can inhibit Ca2þ-induced release of cytochrome c from mito-
chondria.
2. Materials and methods
Mitochondria from hearts of female Wistar rats were isolated by
the method of di¡erential centrifugation as described in [17]. Mito-
chondrial respiration rate was measured with a Clarke-type oxygen
electrode at 37‡C in 1 ml incubation bu¡er containing 110 mM KCl,
2.24 mM MgCl2, 10 mM Tris^HCl, 5 mM nitrilotriacetic acid (NTA),
10 mM mannitol, 5 mM KH2PO4, 4 IU/ml creatine kinase, 50 mM
creatine, 1 mM dithiothreitol and respiration substrate 1 mM pyru-
vate+1 mM malate (pH 7.2). Mitochondrial state 3 respiration rate
was achieved by adding 1 mM ATP. 0.1 mM CaCl2 was added to the
medium in the experiments with high calcium concentrations and free
Ca2þ was calculated as described in [18].
Mitochondrial membrane potential was measured using a tetraphe-
nylphosphonium (TPPþ)-selective electrode (as described in [17]) in
the experiments with estradiol or spectrophotometrically using
10 WM safranine in the experiments with 4-hydroxytamoxifen (to
avoid binding of 4-hydroxytamoxifen to TPPþ-selective electrode
membrane). Changes in absorption were recorded with a dual-wave-
length Hitachi-557 spectrophotometer at wavelengths 484 and 522 nm.
The safranine signal was calibrated (in mV) in experiments where the
TPPþ uptake was also measured in a separate vessel but at the same
time with a TPPþ electrode.
In the experiments on cytochrome c release, isolated heart mito-
chondria (1 mg/ml) were incubated for 5 min under aerobic conditions
in a stirred vessel in a bu¡er containing 110 mM KCl, 10 mM
mannitol, 5 mM NTA, 5 mM KH2PO4, 2.24 mM MgCl2, 50 mM
creatine, 1 mM pyruvate, 1 mM malate, 20 WM ATP, 5 WM free Ca2þ,
pH 7.2, 37‡C, in the presence or absence of 100 nM 17L-estradiol,
100 nM 4-hydroxytamoxifen or 0.2 WM cyclosporin A. In some
experiments 20 mM KH2PO4 (instead of 5 mM) was used to induce
maximal mitochondrial swelling. After incubation mitochondria were
centrifuged at 13 000 rpmU3 min in an Eppendorf centrifuge and
supernatants were used for spectrophotometric measurements of
cytochrome c as described in [17,19]. Total cytochrome c content
was determined in mitochondria solubilized with 1% (w/v) Triton
X-100.
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Mitochondrial swelling was measured spectrophotometrically as de-
crease in absorbance at 540 nm.
Chemicals used in this study were: KCl, Tris^HCl ^ from Roth,
NTA, pyruvate ^ from Merck, KH2PO4, malate ^ from Serva, all
other reagents ^ from Sigma.
3. Results
We investigated whether estrogens at physiological concen-
trations can prevent calcium-induced release of cytochrome c
from mitochondria. After 5 min incubation of mitochondria
in the medium containing 5 WM free Ca2þ, there was substan-
tial increase in cytochrome c level in the supernatants com-
pared with control mitochondrial incubated without Ca2þ
(Fig. 1A). The release of cytochrome c was prevented by 0.2
WM cyclosporin A (Fig. 1A) indicating that it was related to
MPT. In the presence of 100 nM 17L-estradiol or 4-hydroxy-
tamoxifen Ca2þ-induced release of cytochrome c from mito-
chondria was substantially reduced (Fig. 1). Although some
protective e¡ect of estrogens was seen in the absence of added
ATP, statistically signi¢cant protection by estrogens was ob-
served in the presence of low, 20 WM, concentrations of ATP,
which in our experimental conditions should be converted to
ADP by mitochondrial creatine kinase in the presence of cre-
atine. L-Estradiol also signi¢cantly reduced cytochrome c re-
lease induced by calcium and high phosphate (20 mM), sim-
ilar to the e¡ect of cyclosporin A (Fig. 1B). As can be seen
from Fig. 2, the release of cytochrome c was accompanied by
cyclosporin A-sensitive mitochondrial swelling, indicating
MPT. However, swelling was not extensive, being only about
10% of that induced by Ca2þ and high (20 mM) phosphate
concentration (Fig. 2). Not that high-amplitude swelling in-
duced by Ca2þ and 20 mM phosphate was also prevented by
cyclosporin A. However, Ca2þ-induced swelling was insensi-
tive to 17L-estradiol or 4-hydroxytamoxifen (Fig. 2), suggest-
ing that these agents did not prevent Ca2þ accumulation in
mitochondria. Further support for this was obtained in ex-
periments where mitochondrial respiration rate was measured.
Incubation of mitochondria in medium with 5 WM free Ca2þ
resulted in a time-dependent (due to accumulation of Ca2þ in
mitochondria) decrease in state 3 respiration rate and after 5
min incubation the steady-state respiratory rate was 217Q 28
natom O/min/mg in Ca2þ-treated mitochondria compared to
284Q 25 natom O/min/mg in untreated control mitochondria
(P6 0.05). 100 nM 17L-estradiol and 4-hydroxytamoxifen did
not prevent Ca2þ-induced inhibition of state 3 respiration
rate: 194Q 19 and 193Q21 natom O/min/mg in the presence
of estradiol and 4-hydroxytamoxifen, respectively, suggesting
that estrogens at low concentration did not inhibit Ca2þ up-
take by mitochondria.
Next we tested whether the protective e¡ect of estrogens
could be related to estrogen-induced changes in mitochondrial
respiratory rate or membrane potential. As can be seen from
Fig. 3, 10 nM^10 WM of estradiol had no e¡ect on mitochon-
drial respiration and membrane potential. Higher concentra-
tions of estradiol (50^100 WM) decreased state 3 respiration
and membrane potential by about 30^50% (Fig. 3A). State 4
respiration rate was not a¡ected by 17L-estradiol, however
membrane potential was signi¢cantly inhibited by high con-
centrations of estradiol (Fig. 3B). Similar results were ob-
tained with 4-hydroxytamoxifen: 10 nM^10 WM of 4-hydroxy-
tamoxifen had no e¡ect on mitochondrial respiration and
membrane potential in state 3 and state 4, however at 50 WM
concentration it inhibited both investigated parameters
(Fig. 4). These data show that in the range of physiological,
nanomolar concentrations 17L-estradiol (as well as 4-hydroxy-
tamoxifen) does not a¡ect mitochondrial respiratory func-
tions; inhibition occurs only at high, non-physiological con-
centrations.
Fig. 1. E¡ect of estrogens on the amount of cytochrome c released
from mitochondria. A: Mitochondria (1 mg/ml protein) were incu-
bated at 37‡C for 5 min in the medium containing 110 mM KCl,
10 mM Tris^HCl, 10 mM mannitol, 5 mM NTA, 5 mM KH2PO4,
1 mM free Mg2þ, 50 mM creatine, 1 mM pyruvate and 1 mM ma-
late, 20 WM ATP, 5 WM free Ca2þ. Where indicated, 100 nM 17L-
estradiol, 100 nM 4-hydroxytamoxifen, were added or ATP ex-
cluded. Control ^ mitochondria incubated in the same medium but
without calcium. Mitochondria were removed by centrifugation, the
supernatants were used for measurement of released cytochrome c.
The total mitochondrial cytochrome c content was 0.379Q0.022
nmol/mg protein. B: Mitochondria were incubated under similar
conditions as in (A) (in the presence of 20 WM ATP), but the incu-
bation medium contained 20 mM KH2PO4. 0.2 WM cyclosporin A
was added where indicated. * ^ statistically signi¢cant di¡er-
ence compared to control, # ^ compared to 5 WM Ca2þ, P6 0.05
(n=5^8).
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4. Discussion
The present study for the ¢rst time reports that at physio-
logical, nanomolar concentrations 17L-estradiol and 4-hy-
droxytamoxifen prevent calcium-induced release of cyto-
chrome c from heart mitochondria. It has been previously
shown that tamoxifen, and estrogen receptor agonist/antago-
nist, like cyclosporin A, inhibits induction of MPT in rat liver
mitochondria [12] and cultured neurons [13]. We hypothesized
that similar e¡ect might be exerted by a metabolite of tamox-
ifen, 4-hydroxytamoxifen, and 17L-estradiol, thus we studied
the e¡ect of these agents on MPT-related release of cyto-
chrome c from mitochondria. Calcium-induced release of cy-
tochrome c from isolated mitochondria is known to be related
to opening of MPT [6,17,20]. We observed that at nanomolar
concentrations both 4-hydroxytamoxifen and 17L-estradiol
prevented calcium-induced loss of cytochrome c from heart
mitochondria. The protective e¡ect of estrogens was greatly
enhanced in the presence of low micromolar concentrations of
adenine nucleotides, which suggests possible involvement of
the ATP/ADP translocator, a component of MPT. However,
in contrast to cyclosporin A, estrogens did not inhibit Ca2þ-
induced mitochondrial swelling. This suggests that: (i) the
release of cytochrome c from mitochondria was not related
to mitochondrial swelling; and (ii) the protective actions of
estrogens are not due to blocking swelling. We do not think
that the protective e¡ect of estrogens is due to inhibition of
Ca2þ uptake by mitochondria because we found that Ca2þ
inhibited mitochondrial respiration to the same extend in
the presence or absence of 17L-estradiol and 4-hydroxytamox-
ifen. Moreover, estrogens did not prevent Ca2þ-induced mi-
tochondrial swelling. Consistent with this, it has previously
been shown that estradiol does not inhibit the uptake of
Ca2þ by rat brain mitochondria [21]. It has been suggested
that estrogens might stimulate Ca2þ e¥ux through the Naþ/
Ca2þ antiporter [21], however such an e¡ect is unlikely in our
experimental conditions where Naþ-free mitochondrial incu-
bation bu¡ers (and reagents) were used.
High concentrations of estrogens have a damaging e¡ect on
heart mitochondrial functions. We show that 50^100 WM es-
trogens strongly inhibit mitochondrial respiration and mem-
brane potential presumably due to decreased activity of the
Fig. 2. E¡ect of estrogens on Ca2þ-induced mitochondrial swelling.
Mitochondria (0.5 mg/ml) were incubated under the same conditions
(with 20 WM ATP) as in Fig. 1 for 5 min. Where indicated 100 nM
17L-estradiol, 100 nM 4-hydroxytamoxifen, 0.2 WM cyclosporin A
or 20 mM phosphate were added. Representative traces of ¢ve ex-
periments are shown.
Fig. 3. The e¡ect of 17L-estradiol on heart mitochondrial respiration
rate and membrane potential in state 3 (A) and state 4 (B). Isolated
female rat heart mitochondria were incubated with 10 nM^100 WM
of 17L-estradiol for 5 min at 37‡C. MeansQ standard errors of four
separate experiments are presented. State 3 respiration rate in con-
trol without 17L-estradiol was 295Q 23 natom O/min/mg protein,
membrane potential 129Q 4 mV, in state 4 ^ respectively 43Q 2 and
157Q 2.5. *P6 0.05 compared to control,. b ^ respiration rate, F ^
membrane potential.
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respiratory chain. The inhibition of the respiratory chain may
be due to non-speci¢c binding of estrogens to hydrophobic
regions of the mitochondrial membranes [16,22], which may
change protein^lipid interactions, disturb electron transport
through the inner mitochondrial membrane and reduce mem-
brane potential. Tamoxifen and 4-hydroxytamoxifen have
been shown to inhibit electron transport at the levels of com-
plex III and complex IV [23]. Rat brain mitochondrial F0F1-
ATPase has been also shown to be a target for estradiol and
related estrogenic compounds [24], therefore, state 3 respira-
tion with high concentrations of estradiol may be inhibited
due to inhibition of the ATPase.
In conclusion, the present study provides evidence that at
physiological concentrations, which do not inhibit mitochon-
drial functions, estrogens can protect heart mitochondria from
the loss of cytochrome c induced by high calcium, and this
might be one of the possible mechanisms by which estrogens
preserve myocardial cell viability after ischemia/reperfusion.
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Fig. 4. The e¡ect of 4-hydroxytamoxifen on heart mitochondrial res-
piration rate and membrane potential in state 3 (A) and state 4 (B).
Experimental conditions were as in Fig. 3. MeansQ standard errors
of four separate experiments are presented. State 3 respiration rate
in control without 4-hydroxytamoxifen was 278Q 28 natom O/min/
mg protein, membrane potential 144Q 3 mV, in state 4 ^ respec-
tively 45Q 2 and 158Q 24. * ^ P6 0.05 compared to control. b ^
respiration rate, F ^ membrane potential.
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